CureVac (NASDAQ:CVAC) | WebDisclosure

BRIEF

published on 11/12/2024 at 13:05, 1 month 9 days ago

CureVac publie ses résultats financiers du troisième trimestre et ses mises à jour commerciales pour 2024

Résultats Financiers Restructuration Stratégique Technologie De L'ARNm Développement En Oncologie Collaboration GSK
BRIEF

published on 11/12/2024 at 13:05, 1 month 9 days ago

CureVac Reports Q3 Financial Results and Business Updates for 2024

Financial Results MRNA Technology Strategic Restructuring GSK Collaboration Oncology Development
PRESS RELEASE

published on 11/12/2024 at 13:00, 1 month 9 days ago

CureVac Announces Financial Results for the Third Quarter and First Nine Months of 2024 and Provides Business Update
CureVac announces financial results for the third quarter of 2024, including strengthened cash position, new oncology and prophylactic vaccine programs, workforce reduction, and new CFO appointment

Financial Results Oncology CureVac Prophylactic Vaccines Workforce Reduction
BRIEF

published on 11/07/2024 at 13:05, 1 month 14 days ago

CureVac annonce ses prochains résultats financiers et sa mise à jour commerciale

Résultats Financiers Conférence Téléphonique Mise À Jour De L'entreprise CureVac Technologie De L'ARNm
BRIEF

published on 11/07/2024 at 13:05, 1 month 14 days ago

CureVac Announces Upcoming Financial Results and Business Update

Financial Results Conference Call Business Update MRNA Technology CureVac
PRESS RELEASE

published on 11/07/2024 at 13:00, 1 month 14 days ago

CureVac to Report Third Quarter and First Nine Months 2024 Financial Results and Business Update on November 12, 2024
CureVac to report financial results for Third Quarter and First Nine Months 2024 on November 12, 2024. Learn about the business update in the upcoming webcast

Financial Results Business Update MRNA Technology Q3 2024 CureVac
BRIEF

published on 11/04/2024 at 13:08, 1 month 17 days ago

CureVac Appoints Axel Sven Malkomes as CFO

Chief Financial Officer Biopharmaceutical MRNA Technology CureVac Axel Sven Malkomes
BRIEF

published on 11/04/2024 at 13:08, 1 month 17 days ago

CureVac nomme Axel Sven Malkomes au poste de directeur financier

Biopharmaceutique Directeur Financier CureVac Technologie De L'ARNm Axel Sven Malkomes
BRIEF

published on 11/04/2024 at 13:05, 1 month 17 days ago

CureVac to Showcase Data at 12th International mRNA Health Conference

Oncology Cancer Vaccine CureVac MRNA Health Conference LNP Delivery
BRIEF

published on 11/04/2024 at 13:05, 1 month 17 days ago

CureVac présentera ses données lors de la 12e Conférence internationale sur la santé de l'ARNm

Oncologie Vaccin Contre Le Cancer CureVac Conférence Sur La Santé De L'ARNm Livraison LNP

Published on 12/21/2024 at 01:30, 17 hours 25 minutes ago

Quantum Biopharma Announces Closing of Second Tranche
Published on 12/21/2024 at 01:30, 17 hours 25 minutes ago

iMetal Resources Closes First Tranche of Previously Announced Non-Brokered Private Placement
Published on 12/21/2024 at 00:05, 18 hours 50 minutes ago

Chloeta Awarded GSA OASIS+ IDIQ Contract for Intelligence, Federal Civilian and Defense Support Services
Published on 12/21/2024 at 00:00, 18 hours 55 minutes ago

Amarc Announces Loan Extension
Published on 12/20/2024 at 23:30, 19 hours 25 minutes ago

Boron One Announces Extension to Early Warrant Exercise Incentive Program

View all ACCESSWIRE

Published on 12/21/2024 at 00:51, 18 hours 4 minutes ago

Acquisition of PSI Transcom GmbH by CHAPTERS platform Altamount Software GmbH
Published on 12/21/2024 at 00:45, 18 hours 10 minutes ago

EQS-Adhoc: PSI sells the Mobility business unit
Published on 12/20/2024 at 19:10, 23 hours 45 minutes ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 12/20/2024 at 18:56, 23 hours 59 minutes ago

CPI PROPERTY GROUP – Progress on Key Initiatives
Published on 12/20/2024 at 18:00, 1 day ago

ARYZTA AG Announces New Board Technology Committee

View all EQS

Published on 12/21/2024 at 12:17, 6 hours 37 minutes ago

AXA annonce la signature d’un accord relatif à la vente d'AXA Investment Managers à BNP Paribas
Published on 12/21/2024 at 12:17, 6 hours 37 minutes ago

AXA announces the signing of a share purchase agreement with BNP Paribas relating to the sale of AXA IM
Published on 12/20/2024 at 18:00, 1 day ago

Kapitaalverhoging door uitoefening van inschrijvingsrechten
Published on 12/20/2024 at 18:00, 1 day ago

Capital increase through exercise of subscription rights
Published on 12/20/2024 at 17:55, 1 day 1 hour ago

Déclaration des transactions sur actions propres réalisées du 16/12/2024 au 20/12/2024

View all LES ECHOS COMFI WIRE

News